Identification of a novel EphB4 inhibitor, Sanguinarine, which attenuates β-catenin signaling to inhibit tumor proliferation and migration in lung cancer
Journal of Advanced Research · 2026-11 · 89 · 1077-1092
DOI: 10.1016/j.jare.2026.02.044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Advanced Research, 2026-11. Verfasst von Asmat Ullah und 9 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery, Cancer Center, Department of Hepatobiliary & Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospita…. Hauptthemen laut MEDLINE: Lung Neoplasms, Receptor, EphB4, Benzophenanthridines, Isoquinolines. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medical Science and Technology Project of Zhejiang Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- General Surgery, Cancer Center, Department of Hepatobiliary & Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou 31…
- Urology & Nephrology Center, Department of Urology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou 310014, Zhejiang, China.
- Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou 325027, Zhejiang, China.
- College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310012, China.
- Urology & Nephrology Center, Department of Urology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou 310014, Zhejiang, China; Division of Surgery & Interventional S…
- Department of Hepatopancreatobiliary Surgery, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning 110042, China.
Förderung
- Medical Science and Technology Project of Zhejiang Province
Zitieren
APA
Ullah, A., Zhou, C., Xiao, W., Iqbal, H., Zhang, F., Nan, P., Khan, N. U., Feng, D., Liu, Y., & Tao, R. (2026). Identification of a novel EphB4 inhibitor, Sanguinarine, which attenuates β-catenin signaling to inhibit tumor proliferation and migration in lung cancer. Journal of Advanced Research, 89, 1077-1092. https://doi.org/10.1016/j.jare.2026.02.044
Vancouver
Ullah A, Zhou C, Xiao W, Iqbal H, Zhang F, Nan P, et al. Identification of a novel EphB4 inhibitor, Sanguinarine, which attenuates β-catenin signaling to inhibit tumor proliferation and migration in lung cancer. Journal of Advanced Research. 2026;89:1077-1092. doi:10.1016/j.jare.2026.02.044
BibTeX
@article{Ullah2026,
author = {Ullah, Asmat and Zhou, Chuanzan and Xiao, Wang and Iqbal, Haroon and Zhang, Facai and Nan, Peng and Khan, Naveed Ullah and Feng, Dechao and Liu, Yefu and Tao, Ran},
title = {Identification of a novel EphB4 inhibitor, Sanguinarine, which attenuates β-catenin signaling to inhibit tumor proliferation and migration in lung cancer},
journal = {Journal of Advanced Research},
year = {2026},
volume = {89},
pages = {1077--1092},
doi = {10.1016/j.jare.2026.02.044}
}
EUVIMED